HSQY supplies pharmaceutical PVC film and laminated medicinal sheets for thermoformed blister packaging of tablets, capsules, pills, suppositories and selected healthcare products. The product range includes rigid PVC film, PVC/PE film, PVC/PVDC film and PVC/PVDC/PE composite film in clear, tinted and opaque colors.
Pharmaceutical blister packaging must be selected as a complete system. The forming web, aluminum lidding foil, blister cavity, sealing lacquer, packaging machine, drug sensitivity, storage climate and required shelf life all influence final performance. HSQY can provide custom thicknesses, roll widths, colors, coating structures and trial material for packaging-line evaluation.
Quick answer: Pharmaceutical PVC film is a non-plasticized rigid forming web used to thermoform blister cavities for solid-dose medicines. Standard PVC provides good clarity, forming performance and cost efficiency. Moisture-sensitive or oxygen-sensitive products generally require a higher-barrier structure such as PVC/PVDC, PVC/PVDC/PE, PCTFE laminate or cold-form foil, selected through stability and packaging validation.
HSQY offers multiple pharmaceutical forming-film structures. Each structure provides a different balance of thermoformability, barrier performance, mechanical strength and cost.
| Film Structure | Main Characteristics | Typical Applications |
|---|---|---|
| Rigid PVC Pharmaceutical Film | Clear, economical and easy to thermoform on common rotary and platen blister machines. Provides basic protection but has lower moisture and oxygen barrier than coated or laminated films. | Stable tablets, capsules, pills and products with moderate barrier requirements. |
| PVC/PVDC Coated Film | PVDC coating improves resistance to water vapor, oxygen and aroma transmission. Different coating weights can be selected according to barrier requirements. | Moisture-sensitive tablets, capsules, nutraceuticals and products sold in humid climates. |
| PVC/PE Composite Film | Combines rigid PVC with a PE layer that supports sealing, flexibility or specialized packaging structures. | Suppository packs, selected liquid-dose units and specialized pharmaceutical or healthcare packaging. |
| PVC/PVDC/PE Composite Film | Multilayer structure combining barrier protection with improved forming behavior for deeper cavities or demanding products. | Hygroscopic products, deeper blister cavities and products requiring enhanced moisture and oxygen protection. |
| Colored or Opaque PVC Film | Available in transparent tints and opaque colors for identification, branding or partial light protection. | Color-coded product lines and selected light-sensitive formulations after stability testing. |
Browse the products above to compare available pharmaceutical film grades. Related options include PVC film for pharmaceutical packaging, 0.25 mm transparent medical PVC sheet, PVC/PE film for suppository packaging and the PVDC-coated PVC film range.
HSQY supplies several product families with different dimensional ranges. The table below summarizes common blister-film specifications. Final values must be confirmed for the exact material structure and production grade.
| Specification | Typical HSQY Options |
|---|---|
| Materials | Rigid PVC, PVC/PE, PVC/PVDC and PVC/PVDC/PE |
| Common Blister-Film Thickness | Approximately 0.13–0.50 mm for pharmaceutical blister-film series; 0.20–0.30 mm is common for many solid-dose applications |
| Wider Medical Sheet Range | Selected medical and laminated sheet products are available outside the standard blister range; confirm suitability before specifying thicker material |
| Roll Width | Common widths include 130 mm, 225 mm, 245 mm and 250 mm; custom slit widths may be supplied within the selected line capability |
| Maximum Web Width | Up to approximately 800–1280 mm for selected structures before slitting |
| Core Diameter | 76 mm is available for selected roll products; other cores should be confirmed before production |
| Maximum Roll Diameter | Up to approximately 600 mm for selected pharmaceutical film structures |
| Colors | Clear, transparent blue tint, white, amber, red, green, yellow and custom colors subject to formulation review |
| Surface | Glossy as standard for many blister-film grades; selected matte, frosted or specialty surfaces are available for nonstandard applications |
| MOQ | Commonly 1000–2000 kg depending on structure, thickness, color, width and documentation requirements |
| Typical Lead Time | Approximately 7–15 days after technical specification and commercial order confirmation for selected products |
Specification note: A broad “medical PVC sheet” range should not be confused with a qualified pharmaceutical blister film. Primary drug packaging requires a controlled formulation, defined quality specification, traceable production and application-specific supporting documentation.
| Selection Factor | Rigid PVC | PVC/PVDC | PVC/PVDC/PE |
|---|---|---|---|
| Moisture Barrier | Basic to moderate | Higher, depending on PVDC coating weight and forming | Higher barrier with a structure designed for demanding forming and product protection |
| Oxygen Barrier | Limited compared with barrier laminates | Improved | Improved; final value depends on complete structure and forming depth |
| Thermoforming | Good and widely understood on standard blister lines | Good when heating is controlled to protect coating uniformity | Suitable for selected deeper-draw applications after line testing |
| Relative Cost | Lowest of the three options | Higher than mono PVC | Higher because of multilayer construction and processing |
| Typical Product | Stable oral solid dosage forms | Moisture-sensitive tablets and capsules | Hygroscopic products, deep cavities and demanding climates |
Barrier selection must be based on packaged-product stability data. A higher-barrier film may be unnecessary for a stable product, while standard PVC may be inadequate for a hygroscopic drug sold in a hot and humid climate.
Web unwinding: The pharmaceutical PVC roll is unwound under controlled tension.
Heating: The forming web passes through heating plates or rollers until it reaches the required forming condition.
Thermoforming: Vacuum, compressed air, plug assistance or a combination forms the blister cavities.
Product filling: Tablets, capsules or other units are placed in the formed cavities.
Lidding application: Heat-seal-lacquered aluminum foil or another qualified lidding material is placed over the forming web.
Heat sealing: Controlled temperature, pressure and dwell time activate the lacquer and create the package seal.
Inspection and punching: The web is checked, coded and cut into finished blister cards.
The PVC film itself does not normally provide all package functions. The final blister pack consists of the formed web, lidding foil, heat-seal system and the geometry created by the machine tooling.
High-ranking pharmaceutical film suppliers emphasize controlled shrinkage, thickness consistency, tight winding and stable forming because these properties directly affect line efficiency. A film that varies across the web can cause uneven cavity walls, web tracking problems, poor registration, seal wrinkles and inconsistent punching.
When evaluating a new pharmaceutical PVC film, provide the blister-machine brand and model, platen or rotary forming system, heating-zone configuration, web width, line speed, cavity depth, draw ratio, indexing length, winding direction and maximum roll diameter.
Web tracking and roll tension stability
Heating uniformity across the forming width
Cavity definition and corner formation
Wall-thickness distribution after forming
Web shrinkage and registration
Whitening, stress marks, bubbles or pinholes
Flange flatness before heat sealing
Punching accuracy and cut-edge quality
Pharmaceutical PVC blister film is commonly sealed to push-through aluminum foil carrying a heat-seal lacquer compatible with the forming web. Successful sealing depends on the lacquer chemistry, PVC or coated-film surface, sealing temperature, pressure, dwell time, flange cleanliness and machine tooling.
Before commercial production, test the exact forming film with the intended lidding foil. Evaluate seal strength, channel leakage, foil delamination, opening force, push-through performance and seal consistency after storage and stability conditioning.
Important: Terms such as tamper-evident, child-resistant or senior-friendly describe the performance of a finished package design. They cannot be guaranteed by the PVC forming film alone and require complete-package testing against the applicable standard.
Tablet blister packs
Hard and soft capsule blister packs
Pill and nutraceutical blister packaging
Suppository and unit-dose packaging using a compatible laminated structure
Veterinary medicine blister packs
Clinical-trial and sample-dose packs
Selected diagnostic-kit components and healthcare-product trays after qualification
Non-sterile medical-device presentation trays where the material and packaging process are validated
Sterility note: Standard pharmaceutical PVC film should not automatically be described as a sterile barrier material. Medical-device packaging and terminal sterilization require structure-specific validation for the sterilization method, seal system, microbial barrier and product shelf life.
Clear PVC provides product visibility and supports visual inspection of tablets and capsules. Transparent blue or other tints may be used for product differentiation, machine inspection or brand presentation. Opaque white, amber or custom colors can reduce light transmission, but color alone should not be treated as proof of adequate light protection.
For light-sensitive products, define the required spectral transmission or light-protection performance and confirm it through stability studies. Pigments and colorants must also be included in the finished material's safety and regulatory assessment.
The forming film must protect the medicine throughout its approved shelf life. The required barrier depends on the drug formulation, tablet coating, capsule shell, cavity dimensions, exposed film area, storage climate, secondary packaging and distribution conditions.
Ask the following questions before choosing a structure:
Is the product sensitive to moisture, oxygen, light or aroma loss?
What shelf life must be achieved?
Which climatic zone and distribution route apply?
What cavity depth and formed-film surface area are required?
Will the blister cards be packed in cartons, pouches or overwraps?
Is a desiccant or secondary barrier package used?
What barrier data and stability results are available for the current package?
Unformed-film barrier data are useful for screening, but the formed cavity is thinner than the original web. Final package protection must therefore be verified with the actual cavity geometry and completed blister pack.
Pharmaceutical blister film requires controlled specifications and batch traceability. Depending on the product structure and customer requirements, quality control may include:
| Test Area | Typical Checks | Why It Matters |
|---|---|---|
| Identity and Composition | Material identity, formulation control, coating or laminate structure and approved raw materials. | Confirms that the delivered batch matches the qualified packaging material. |
| Dimensions | Thickness, width, roll length, core size, roll diameter and winding alignment. | Affects forming uniformity, registration, machine setup and material yield. |
| Visual Quality | Clarity, haze, color, black spots, fisheyes, gels, bubbles, streaks and surface contamination. | Supports visual inspection, appearance and uninterrupted machine operation. |
| Thermal Performance | Heat shrinkage, forming window and dimensional response to heating. | Reduces web distortion, registration loss and cavity inconsistency. |
| Mechanical Properties | Tensile behavior, impact resistance, flexural behavior and punching performance as applicable. | Supports forming, handling and finished-pack integrity. |
| Barrier Properties | Water-vapor transmission, oxygen transmission and coating weight when specified. | Supports material selection for moisture- and oxygen-sensitive products. |
| Surface and Seal Compatibility | Surface condition, heat-seal compatibility, coating adhesion and seal-strength trials. | Helps prevent channels, weak seals and inconsistent lidding performance. |
| Chemical Safety | Extractables, migration, elemental impurities, residual substances and other tests defined by the applicable specification. | Supports compatibility and safety assessment for direct pharmaceutical contact. |
There is no single certificate that automatically makes every PVC film suitable for every medicine and market. Pharmaceutical packaging suitability is generally assessed in terms of protection, compatibility, safety and performance for the intended drug product.
Depending on the destination market and customer dossier, requested documentation may include:
Product specification and technical data sheet
Certificate of analysis for each production batch
Material composition and declaration of conformity
Quality-management or manufacturing-site information
Applicable pharmacopoeial test information
Extractables, migration or safety assessment data
Barrier, thermoforming and heat-seal performance data
Change-control and batch-traceability information
Regulatory support documents requested for a drug master file or marketing-authorization dossier
Customers should state whether the material must support requirements associated with the United States, European Union, United Kingdom, Japan or another jurisdiction. Documents such as ISO 9001, SGS, RoHS or REACH reports may be useful, but they do not replace pharmaceutical-product compatibility, stability data or market-specific primary-packaging requirements.
Rigid PVC and laminated PVC structures can be used for selected medical-device trays, diagnostic-kit components and non-sterile healthcare packaging. The required material differs from a standard tablet blister film when the package must withstand sterilization, maintain a sterile barrier or comply with medical-device packaging standards.
Provide the device type, sterilization method, seal system, transport requirements, shelf life and regulatory market before selecting a material. Gamma irradiation, electron beam, ethylene oxide, steam and other sterilization processes can affect polymers differently and require structure-specific validation.
Most variable information such as batch number and expiration date is applied to the finished blister pack or lidding foil during packaging. Custom color, printed registration marks or specialized surface treatment may be available for selected PVC structures, but direct printing on the forming web must be validated for ink adhesion, migration risk, machine registration and drug-product contact.
Provide artwork, number of colors, printed side, repeat length, eye-mark size, winding direction and whether the ink will face the product, adhesive or external surface. Pharmaceutical printing should use a controlled and approved ink system.
| Problem | Possible Causes | Recommended Checks |
|---|---|---|
| Incomplete or Shallow Cavities | Insufficient heating, short dwell time, poor vacuum or pressure, incorrect grade or low mold venting. | Verify actual web temperature, heating uniformity, vacuum, compressed air, tooling and film orientation. |
| Excessive Shrinkage or Registration Loss | Overheating, long heating time, unstable tension or unsuitable thermal characteristics. | Reduce thermal exposure, confirm shrinkage specification and inspect tension control. |
| Web Tracking Problems | Uneven winding, telescoped roll, variable thickness, core misalignment or machine tension imbalance. | Inspect roll geometry, slit quality, core alignment, web guides and unwind settings. |
| Weak or Channelled Seal | Incompatible lidding lacquer, low temperature, insufficient dwell, poor pressure, contaminated flange or distorted web. | Validate forming-film and foil compatibility and build a controlled sealing window. |
| PVDC Coating Damage | Excessive heat, abrasion, incorrect winding, deep draw beyond material capability or unsuitable handling. | Review forming temperature, cavity geometry, coated-side orientation and roll handling. |
| Bubbles, Gels or Black Spots | Raw-material contamination, degradation, filtration issues or process instability. | Compare defects with the agreed visual limit and investigate batch traceability and process records. |
| Cracking During Punching | Low temperature, excessive brittleness, blunt tooling, incorrect clearance or unsuitable formulation. | Condition the web, inspect punch tooling and test mechanical properties of the film. |
Store rolls in their original packaging in a clean, dry and temperature-controlled area.
Protect the film from direct sunlight, moisture, dust, strong odors and corrosive chemicals.
Keep rolls upright or supported according to the supplier's packing design to prevent edge damage and telescoping.
Do not drag rolls across the floor or lift them by unsupported film edges.
Allow material to equilibrate to the production-room temperature before opening the moisture-protective packaging when required.
Apply first-in, first-out inventory control and maintain batch identity throughout slitting and packaging.
Follow the confirmed shelf-life and storage conditions stated for the exact film grade.
Rigid PVC is not biodegradable or home-compostable. Pharmaceutical blister packs are also difficult to recycle in many markets because the PVC or barrier forming web is sealed to aluminum foil and the packs may retain medicine residue.
Potential improvement measures include reducing film thickness without compromising performance, selecting the lowest barrier structure that meets stability requirements, optimizing cavity geometry, reducing production scrap, segregating clean factory waste and evaluating established blister-pack collection programs where available.
PVC-free alternatives such as mono-PP, APET, cyclic olefin structures or aluminum-based cold-form packaging may be considered, but each alternative changes forming performance, barrier, machinery, cost and regulatory documentation. A material change requires a new technical and stability assessment.
Pharmaceutical PVC film is typically supplied in tightly wound rolls protected with PE film, kraft paper, end protection and export pallets. Packing configuration depends on roll width, roll weight, core size, maximum roll diameter and customer handling equipment.
Before ordering, confirm:
Maximum roll weight accepted by the packaging line
Core inside diameter and core material
Maximum roll outside diameter
Winding direction and coated-side orientation
Number and type of permitted splices
Roll identification and batch-label format
Pallet size, gross weight and stacking restrictions
Container loading and moisture-protection requirements
Rigid PVC, PVC/PE, PVC/PVDC and PVC/PVDC/PE product options
Custom thickness, slit width, roll diameter, core and winding configuration
Clear, tinted and opaque color development
Grades for standard and higher-barrier pharmaceutical blister packaging
Sample and trial-roll support for blister-line testing
Batch specifications, test documents and export documentation subject to the confirmed grade
Bulk roll packaging and international shipment support
Related PVDC-coated film and pharmaceutical packaging material supply
To receive an accurate material recommendation and quotation, provide:
Drug dosage form and product sensitivity
Current forming-film structure and supplier specification
Required PVC thickness and PVDC coating weight, if applicable
Film width, core diameter, roll diameter and roll weight
Blister-machine model, forming type and line speed
Cavity dimensions, draw depth and blister-card layout
Aluminum lidding foil and heat-seal lacquer type
Required moisture, oxygen and light barrier
Color, printing or coating requirements
Destination market and required regulatory documents
Trial quantity, commercial quantity and annual demand
Packaging, pallet and delivery requirements
Contact HSQY through the inquiry page to request technical data, samples, trial rolls and bulk pricing.
Pharmaceutical PVC film is a rigid, normally non-plasticized forming web used to thermoform blister cavities for tablets, capsules and other unit-dose products. It is sealed to a compatible lidding material to create the finished blister pack.
Common pharmaceutical blister-film thicknesses are approximately 0.20–0.30 mm, although HSQY's pharmaceutical product range extends from about 0.13–0.50 mm. The correct thickness depends on cavity size, draw depth, product weight, machine conditions and required mechanical strength.
Rigid PVC provides good clarity and thermoforming at a relatively low cost but has limited moisture and oxygen barrier compared with coated films. PVC/PVDC has a PVDC barrier coating that improves protection for moisture-sensitive and oxygen-sensitive medicines.
It is a multilayer pharmaceutical forming film combining a PVC base, a PVDC barrier layer and a PE intermediate or functional layer. The structure can provide enhanced barrier and forming performance for selected deep-draw or hygroscopic-product applications.
No. Standard rigid PVC provides basic protection but is not considered a high moisture- or oxygen-barrier material. Products requiring more protection may need PVC/PVDC, PCTFE laminate, COC-based film or cold-form aluminum, subject to stability testing.
Yes. Rigid PVC blister film is commonly sealed to aluminum lidding foil coated with a compatible heat-seal lacquer. The exact foil, lacquer and sealing window must be tested with the forming film and packaging machine.
Available options can include clear, transparent blue tint, white, amber, red, green, yellow and other custom colors. Colorants and opacity levels must be approved for the intended pharmaceutical-contact application.
A colored or opaque film can reduce light transmission, but adequate protection must be demonstrated using defined spectral or stability testing. The visible color alone is not sufficient evidence of light-barrier performance.
Selected rigid PVC structures can be used for non-sterile trays and healthcare-product packaging. Sterile medical-device packaging requires specific validation of the material, seal, sterilization process, microbial barrier, transport performance and shelf life.
PVC film by itself is not child-resistant. Child resistance depends on the complete blister design, lidding structure, opening mechanism and testing against the applicable child-resistant packaging standard.
Standard pharmaceutical PVC film is not automatically supplied as a sterile material. Sterility and sterile-barrier performance apply only when the material and complete packaging process are specifically manufactured, sterilized and validated for that purpose.
Common causes include insufficient or uneven heating, short dwell time, poor vacuum or compressed air, unsuitable film thickness, excessive draw depth, blocked mold vents or incorrect machine tension.
Testing may include identity, thickness, width, visual defects, color, haze, thermal shrinkage, forming performance, mechanical properties, barrier transmission, coating weight, heat-seal compatibility, migration, extractables and other tests required by the agreed specification.
No. ISO 9001 relates to a quality-management system. Pharmaceutical-contact suitability also requires a defined material specification, safety and compatibility evidence, performance testing, batch control and the documentation required by the destination market and drug-product dossier.
Clean rigid PVC production scrap may be recyclable where appropriate facilities exist. Used pharmaceutical blister packs are difficult to recycle in many markets because they combine plastic and aluminum and may contain medicine residue. Local collection rules should be checked.
No. Conventional PVC is not biodegradable or home-compostable. Environmental claims should focus on verified material reduction, manufacturing scrap recovery, collection systems or validated alternative structures.
HSQY product pages commonly list an MOQ of approximately 1000–2000 kg, depending on the structure, width, thickness, color and documentation requirements. Custom PVDC coating weights or specialty formulations may require a different quantity.
Yes. Samples or trial rolls can be evaluated for machine tracking, cavity formation, heat sealing, punching, visual quality and package integrity. Provide the current specification and blister-machine details to improve sample selection.
Provide the film structure, thickness, width, roll diameter, core, color, coating weight, cavity depth, machine model, lidding foil, regulatory market, required documents, trial quantity and annual demand.
Product Category